A 65-year-old man with a history of alcohol-associated cirrhosis, chronic obstructive pulm… — USMLE Step 2 CK

A $65$ -year-old man with a history of alcohol-associated cirrhosis, chronic obstructive pulmonary disease (COPD), and a recent admission for an upper gastrointestinal bleed one month ago presents to the emergency department with a $2$ -day history of progressively worsening shortness of breath, increased abdominal girth, and mild lethargy.

Vital signs are:

Parameter	Value
Temperature	$37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ )
Heart Rate	$102/\text{min}$
Blood Pressure	$95/60 \text{ mmHg}$
Respiratory Rate	$22/\text{min}$
$\text{SpO}_2$ (Room Air)	$89\%$

Physical examination reveals an alert but mildly lethargic patient who is oriented to person and place only. Scleral icterus is present. Jugular venous pulsation is $6 \text{ cm H}_2\text{O}$ . Lung examination shows decreased breath sounds and dullness to percussion over the right lower two-thirds of the lung field, with scattered end-expiratory wheezes bilaterally. The abdomen is distended, non-tender, and has shifting dullness. Bilateral $2+$ pitting lower extremity edema and asterixis are present.

Laboratory studies reveal the following:

Test	Result	Reference Range
$\text{Na}^+$	$131 \text{ mEq/L}$	$136-145 \text{ mEq/L}$
$\text{K}^+$	$2.9 \text{ mEq/L}$	$3.5-5.0 \text{ mEq/L}$
$\text{Cl}^-$	$88 \text{ mEq/L}$	$98-106 \text{ mEq/L}$
$\text{HCO}_3^-$	$38 \text{ mEq/L}$	$22-28 \text{ mEq/L}$
$\text{BUN}$	$42 \text{ mg/dL}$	$8-20 \text{ mg/dL}$
Creatinine	$1.9 \text{ mg/dL}$	$0.7-1.3 \text{ mg/dL}$
Total Bilirubin	$3.8 \text{ mg/dL}$	$0.1-1.0 \text{ mg/dL}$
Albumin	$2.3 \text{ g/dL}$	$3.5-5.0 \text{ g/dL}$
Leukocyte count	$7,400/\text{mm}^3$	$4,500-11,000/\text{mm}^3$
Platelet count	$85,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
TSH	$0.6 \text{ } \mu\text{U/mL}$	$0.4-4.0 \text{ } \mu\text{U/mL}$
Free T4	$0.5 \text{ ng/dL}$	$0.9-1.7 \text{ ng/dL}$

Arterial Blood Gas (Room Air):

Test	Result
$\text{pH}$	$7.53$
$\text{PaCO}_2$	$49 \text{ mmHg}$
$\text{PaO}_2$	$56 \text{ mmHg}$

Chest radiograph demonstrates a large right-sided pleural effusion without mediastinal shift or focal consolidations. A diagnostic paracentesis yields clear, yellow fluid with a total protein of $1.1 \text{ g/dL}$ and a neutrophil count of $80/\text{mm}^3$ . The patient is currently receiving intravenous piperacillin-tazobactam, which was started empirically by a transferring facility $24$ hours ago for presumed pneumonia.

Which of the following is the most appropriate next step in the management of this patient?

Therapeutic thoracentesisAnswer
B
Intravenous methylprednisolone and nebulized ipratropium-albuterol
C
Initiation of non-invasive positive pressure ventilation (BiPAP)
D
Continuation of piperacillin-tazobactam and addition of vancomycin
E
Administration of intravenous levothyroxine

Answer

Therapeutic thoracentesis

The correct answer is therapeutic thoracentesis. This patient is presenting with acute respiratory distress and hypoxia secondary to a massive hepatic hydrothorax. Hepatic hydrothorax occurs when ascitic fluid tracks through small fenestrations in the diaphragm into the pleural space (most commonly on the right side). While the definitive first-line medical management involves sodium restriction and diuretics (e.g., spironolactone and furosemide), this patient exhibits acute kidney injury (Cr 1.9 mg/dL), severe hypokalemia, and profound metabolic alkalosis. Administering diuretics in this setting is absolutely contraindicated as it would exacerbate his renal failure and electrolyte abnormalities. Therefore, to urgently relieve his hypoxia and respiratory compromise, a therapeutic thoracentesis is the safest and most appropriate next step. Chest tube placement is contraindicated in hepatic hydrothorax due to the risk of massive fluid, electrolyte, and protein depletion.

Step-by-Step Solution

Analyze the patient's respiratory and fluid status.

The patient has a large right-sided transudative pleural effusion (hepatic hydrothorax) resulting from decompensated cirrhosis, presenting with hypoxia and dyspnea.

The history of cirrhosis, presence of ascites, lack of infectious signs, and a sterile diagnostic paracentesis point to hepatic hydrothorax rather than an infectious or purely pulmonary etiology.

Evaluate the arterial blood gas to interpret the acid-base derangement.

The patient has a primary metabolic alkalosis with appropriate respiratory compensation.

The pH is 7.53 (alkalemia) with an elevated HCO3 of 38 mEq/L. Using the expected compensation formula: Expected PaCO2 = 40 + 0.7 × (38 - 24) = 49.8 mmHg. The measured PaCO2 of 49 mmHg is a perfect compensatory response, definitively ruling out primary hypercapnic respiratory failure.

Assess for contraindications to standard medical management of fluid overload.

Standard medical therapy (diuretics) is currently contraindicated.

First-line therapy for hepatic hydrothorax is sodium restriction and diuretics. However, the patient has acute kidney injury (creatinine 1.9 mg/dL), severe hypokalemia (2.9 mEq/L), and metabolic alkalosis, meaning diuresis would precipitate worsening hepatorenal physiology.

Determine the most appropriate immediate intervention.

Therapeutic thoracentesis must be performed.

Because diuretics are contraindicated and the patient is severely symptomatic (hypoxic), a therapeutic thoracentesis is the safest and most effective next step to relieve the mechanical compression of the lung.

Key Concept

In patients with hepatic hydrothorax and contraindications to diuresis (such as acute kidney injury or severe electrolyte derangements), therapeutic thoracentesis is the immediate next step in management to alleviate respiratory distress. Furthermore, compensatory hypercapnia secondary to metabolic alkalosis should not be mismanaged as primary respiratory failure.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic